1. Home
  2. FNKO vs FHTX Comparison

FNKO vs FHTX Comparison

Compare FNKO & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

N/A

Current Price

$6.07

Market Cap

323.3M

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

N/A

Current Price

$5.13

Market Cap

323.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNKO
FHTX
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.3M
323.4M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
FNKO
FHTX
Price
$6.07
$5.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$6.00
$11.50
AVG Volume (30 Days)
581.0K
356.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.32
EPS
N/A
N/A
Revenue
$908,209,000.00
$30,909,000.00
Revenue This Year
$4.42
$8.89
Revenue Next Year
$6.50
$20.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.75
52 Week Low
$2.22
$3.27
52 Week High
$6.26
$6.95

Technical Indicators

Market Signals
Indicator
FNKO
FHTX
Relative Strength Index (RSI) 62.17 52.40
Support Level $5.10 $4.37
Resistance Level N/A $5.53
Average True Range (ATR) 0.26 0.37
MACD 0.02 -0.09
Stochastic Oscillator 88.75 19.89

Price Performance

Historical Comparison
FNKO
FHTX

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: